Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma, with an annual US incidence of >25,000 cases. Patients with DLBCL have highly variable course, response to treatment, and prognosis, which depend on many clinical, morphological, phenotypic, and genetic parameters. Nodal and extranodal DLBCLs differ in clinical presentation, behavior, and prognosis. DLBCL is composed of sheets of intermediate to large cells displaying centroblastic or immunoblastic cytomorphology. DLBCL with immunoblastic morphology is characterized by large nuclei with a fine chromatin and a single, centrally located prominent macronucleolus with variable amounts of eosinophilic to amphophilic cytoplasm. DLBCL with anaplastic features shows marked pleomorphism of tumor cells that may resemble Reed–Sternberg cells or carcinoma cells. Occasional cases of DLBCL form cohesive sheets of large cells with an amorphous myxoid background resembling metastatic carcinoma. The biological consequences of BCL6 expression in DLBCL might vary according to the presence or absence and the nature of the underlying alteration of the BCL6 gene.
In a group of 102 patients with myelodysplastic syndrome an evaluation of bone marrow biopsy was performed in order to assess prognostic impact on survival. The following characteristics were included in the analysis: cellularity, erythropoiesis, granulopoiesis, thrombopoiesis, lymphatic nodules, mastocytes, dyserythropoiesis, dysgranulopoiesis, dysthrombopoiesis, blasts, atypical localisation of immature precursor cells, fibrosis, osteoblasts and osteoclasts on bone surfaces. Data were statistically analysed by stepwise Cox proportional hazards regression. Survival was compared between FAB sub-classes, with better prognosis for RA and RARS patients and poor for CMML patients. Better survival was found in patients without dysgranulopoiesis and in those with osteoblasts on bone surfaces. Agreement with established prognostic factors indicates a representative sample. Relationship of osteoblasts to better survival shows involvement of bone tissue in MDS, suggesting it might be useful to include assessment of bone tissue features in histopathologic evaluation.